ArticleScientific reports2026
Development and preliminary psychometric evaluation of a context-specific patient-reported Schizophrenia Disease Burden Scale incorporating socioeconomic and cultural contexts.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Schizophrenia is a chronic, disabling neurocognitive disorder associated with functional, psychological and social burden. Existing patient-reported outcome measures (PROMs), for schizophrenia have largely been developed in non-Indian settings and may not fully capture the lived experiences, contextual realities, and culturally relevant burden constructs of people receiving care in Tamil Nadu. This study aimed to develop and preliminarily evaluate a context-specific Schizophrenia Disease Burden Scale (SDBS) grounded in qualitative inquiry and tailored to Tamil Nadu. A mixed-methods design was adopted. Items were generated through a qualitative in-depth interview with individuals diagnosed with Schizophrenia (n = 10), followed by content validation by an expert panel (n = 11). The resulting questionnaire was administered to 325 participants by initial consecutive sampling followed by snowball sampling. Exploratory factor analysis (principal component analysis with varimax rotation) was performed to identify underlying domains, and internal consistency was assessed using Cronbach's alpha. The initial version of the 65-item scale demonstrated good content validity (S-CVI = 0.87) and high internal consistency (Cronbach's alpha = 0.922). Following the item reduction, a 24-item instrument was obtained with acceptable sampling adequacy (Kaiser-Meyer-olkin value = 0.744) and internal consistency of 0.910. Six domains were identified through exploratory analysis. Confirmatory factor analysis was performed as a preliminary internal structural assessment; however, independent validation is required. The SDBS provides a culturally relevant measure of disease burden that incorporates context-specific domains such as family support, social participation and socio-economic challenges. This initial validation supports its potential utility in Indian settings; however, further studies are required to establish external validity, test-retest reliability and broader applicability across diverse populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.